Skip to main content
. 2024 Jul 29;56(12):1813–1822. doi: 10.3724/abbs.2024122

Figure 1 .


Figure 1

Enzymatic inhibition of SARS-CoV-2 M pro and SARS-CoV-2 M pro mutants by PF-00835231

(A) Inhibitory potency of PF-00835231 against the main protease of the SARS-CoV-2 Mpro K90R. (B) Inhibition of PF-00835231 by the main protease of SARS-CoV-2 Mpro M49I. (C) Inhibition of the main protease of SARS-CoV-2 Mpro G15S by PF-00835231. (D) Inhibition of PF-00835231 against the main protease of SARS-CoV-2 Mpro V186F. (E) Inhibition of PF-00835231 against the main protease of SARS-CoV-2 Mpro P132H. (F) Inhibition of PF-00835231 against the main protease of SARS-CoV-2 Mpro Y54C.